Appointment of Vicki Sloane as CEO of Oxygen
Source: RNS29 July 2024
TruFin plc
("TruFin" or the "Company")
Appointment of Vicki Sloane as Chief Executive Officer of Oxygen Finance ("Oxygen")
TruFin is pleased to announce that Vicki Sloane has today been appointed CEO of Oxygen Finance. Vicki was previously Oxygen's Chief Client Officer ("CCO"), having held various roles since joining the organisation in 2012. As CCO she ran the Early Payment division, Oxygen's largest revenue stream, growing the division by 26% during 2023 and by 29% over the same period in H1 2024.
Vicki replaces Ben Jackson, who has stepped down for personal reasons. During Ben's tenure Oxygen has become the UK's leading provider of early payment programmes and public procurement market insights, processing £27bn in payments to more than 22,000 local authority suppliers annually.
Vicki Sloane, Chief Executive Officer, Oxygen, said:
"After more than a decade in various roles at Oxygen I am delighted to now be leading the organisation. Oxygen has a fantastic team and has built an enviable reputation with customers for delivering successful outcomes. I am looking forward to continuing to help the group build on its market leading position through increased penetration in our target markets."
For further information, please contact:
TruFin plc |
|
Panmure Liberum Limited (Nominated Adviser and Corporate broker) |
0203 100 2000
|
TruFin plc is the holding company of an operating group comprising three growth-focused technology businesses operating in niche markets: early payment provision, invoice finance and mobile games publishing. The Company was admitted to AIM in February 2018 and trades under the ticker symbol: TRU. More information is available on the Company website: www.TruFin.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.